Murray Christopher K. 4
4 · Blueprint Medicines Corp · Filed Oct 30, 2023
Insider Transaction Report
Form 4
Murray Christopher K.
SVP, Technical Operations
Transactions
- Sale
Common Stock
2023-10-26$56.40/sh−600$33,840→ 25,095 total
Footnotes (1)
- [F1]Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.